Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$541M |
| 2 |
Atlassian
TEAM
|
+$452M |
| 3 |
TJX Companies
TJX
|
+$288M |
| 4 |
Corteva
CTVA
|
+$213M |
| 5 |
JPMorgan Chase
JPM
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Microsoft
MSFT
|
+$1.49B |
| 3 |
Amazon
AMZN
|
+$774M |
| 4 |
Meta Platforms (Facebook)
META
|
+$643M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$610M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.37% |
| 2 | Healthcare | 21.1% |
| 3 | Financials | 10.49% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
2526
Agenus
AGEN
$275M
| $65K | ﹤0.01% |
1,698
+4
| +0.2% | +$145 |
|
2527
Amneal Pharmaceuticals
AMRX
$5.99B
| $63K | ﹤0.01% |
19,775
+49
| +0.2% | +$178 |
|
2528
Butterfly Network
BFLY
$1.88B
| $63K | ﹤0.01% |
20,484
+92
| +0.5% | +$318 |
|
|
BTRS
2529
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $63K | ﹤0.01% |
12,690
+316
| +3% | +$1.82K |
|
2530
Angi Inc
ANGI
$252M
| $62K | ﹤0.01% |
1,355
+4
| +0.3% | +$196 |
|
2531
Hyliion Holdings
HYLN
$631M
| $62K | ﹤0.01% |
19,456
+242
| +1% | +$849 |
|
2532
Cricut
CRCT
$987M
| $61K | ﹤0.01% |
+10,015
| New | +$98.6K |
|
|
CTLP
2533
DELISTED
Cantaloupe
CTLP
| $61K | ﹤0.01% |
10,911
+52
| +0.5% | +$276 |
|
2534
MaxCyte
MXCT
$112M
| $61K | ﹤0.01% |
13,000
| – | – |
|
|
AMRS
2535
DELISTED
Amyris Inc.
AMRS
| $61K | ﹤0.01% |
32,418
+670
| +2% | +$1.97K |
|
2536
Hippo Holdings
HIPO
$789M
| $60K | ﹤0.01% |
2,739
+53
| +2% | +$1.96K |
|
|
SFIX
2537
Stitch Fix
SFIX
$563M
| $60K | ﹤0.01% |
12,251
-8
| -0.1% | -$67 |
|
|
EGIO
2538
DELISTED
Edgio, Inc. Common Stock
EGIO
| $59K | ﹤0.01% |
631
| – | – |
|
2539
Ribbon Communications
RBBN
$361M
| $57K | ﹤0.01% |
18,595
-439
| -2% | -$1.33K |
|
2540
Workhorse Group
WKHS
$32.4M
| $57K | ﹤0.01% |
7
| – | – |
|
2541
Oscar Health
OSCR
$9.47B
| $56K | ﹤0.01% |
13,242
+290
| +2% | +$1.84K |
|
2542
Karyopharm Therapeutics
KPTI
$161M
| $55K | ﹤0.01% |
815
+4
| +0.5% | +$367 |
|
|
MRSN
2543
DELISTED
Mersana Therapeutics
MRSN
| $53K | ﹤0.01% |
454
+6
| +1% | +$564 |
|
2544
Alto Ingredients
ALTO
$345M
| $52K | ﹤0.01% |
13,956
-2
| -0% | -$10 |
|
|
PLG
2545
Platinum Group Metals
PLG
$159M
| $52K | ﹤0.01% |
40,165
-152,521
| -79% | -$263K |
|
2546
Quantum-Si Incorporated
QSI
$166M
| $52K | ﹤0.01% |
22,206
+239
| +1% | +$915 |
|
|
HYZN
2547
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $52K | ﹤0.01% |
358
+20
| +6% | +$4.24K |
|
|
IDEX
2548
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $52K | ﹤0.01% |
618
+1
| +0.2% | +$90 |
|
2549
MiMedx Group
MDXG
$649M
| $51K | ﹤0.01% |
14,897
+183
| +1% | +$717 |
|
2550
Heron Therapeutics
HRTX
$92M
| $50K | ﹤0.01% |
17,691
-39
| -0.2% | -$157 |
|
Similar funds
Janus Henderson Group's Q2 2022 Portfolio in Review
As of Q2 2022, Janus Henderson Group held 2,771 positions worth $145B, down 30% from $207B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group withdrew a net $26.6B in Q2 2022, closing 181 positions and reducing 1,519 holdings. Its most notable exit was Cerner Corp, an estimated $139M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Zai Lab worth $66.4M.
- Janus Henderson Group's largest Q2 2022 buy was Zai Lab: 1,913,144 shares worth $66.4M.
- Janus Henderson Group added most to Workday in Q2 2022, an estimated $541M increase.
- Janus Henderson Group's biggest Q2 2022 reduction was Apple, cutting an estimated $2.7B.
- Janus Henderson Group fully exited Cerner Corp in Q2 2022, selling an estimated $139M.
- Janus Henderson Group's ten largest holdings make up 24% of its $145B portfolio in Q2 2022.
- Janus Henderson Group opened 132 new positions and closed 181 in Q2 2022.
- Janus Henderson Group's portfolio value fell 30% quarter-over-quarter to $145B.
Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.